Blood test may predict bone disease severity
NCT ID NCT02868645
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looks at whether a protein called periostin is higher in the blood of people with fibrous dysplasia, a rare bone disease that can cause pain and fractures. Researchers will take blood samples from 65 patients and compare periostin levels to how many bones are affected and how severe the disease is. The goal is to see if a simple blood test could help doctors understand the disease better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could point toward a simple blood test to gauge how severe a patient's fibrous dysplasia is.
- What could go wrong
- This is a small, observational study with only 65 participants. It does not test any treatment, so it may not lead to any direct benefit for patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE FIBROUS DYSPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service de rhumatologie Pavillon F - Hôpital Edouard Herriot
Lyon, 69437, France